The expression of RhoGEF3UAS.EKN.sfGFP under the control of Scer\GAL4ap.PU and Gal80[ts] leads to shortened cell height, formation of epithelial folds and an increase in F-actin levels along the lateral membranes in the dorsal cells of wing imaginal discs, as compared to controls.
The expression of RhoGEF3UAS.EKN.sfGFP under the control of Scer\GAL4GMR.PU at 25[o]C leads to no obvious visible effects on the adult eye, as compared to controls.
Cdc42UAS.cWa, RhoGEF3UAS.EKN.sfGFP, Scer\GAL4GMR.PU has visible | pharate adult stage phenotype
Cdc42UAS.cWa, RhoGEF3UAS.EKN.sfGFP, Scer\GAL4GMR.PU has abnormal size | pharate adult stage phenotype
Rac1UAS.cWa, RhoGEF3UAS.EKN.sfGFP, Scer\GAL4GMR.PU has visible | pharate adult stage phenotype
Cdc42UAS.cWa, RhoGEF3UAS.EKN.sfGFP, Scer\GAL4GMR.PU has eye | pharate adult stage phenotype
Rac1UAS.cWa, RhoGEF3UAS.EKN.sfGFP, Scer\GAL4GMR.PU has eye | pharate adult stage phenotype
The expression of RhoGEF3UAS.EKN.sfGFP in combination with either Cdc42Scer\UAS.cWa or Rac1Scer\UAS.cWa under the control of Scer\GAL4GMR.PU leads to fully penetrant pharate lethality that is associated with a very strong eye defect (residual eye), as compared to controls. Expression of RhoGEF3UAS.EKN.sfGFP in combination with Rho1Scer\UAS.P\T.T:Uuuu\T7 under the control of Scer\GAL4GMR.PU leads to no obvious visible effects on the adult eye, as compared to controls.